Time-Dependent Alterations in Growth and Bone Health Parameters Evaluated at Different Posttreatment Periods in Pediatric Oncology Patients

REFERENCES

• Cohen LE. Endocrine late effects of cancer treatment. Curr Opin Pediatr. 2003;15:3–9.
   Google Scholar
• Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am. 1997;44:489–503.
   PubMed Web of Science ®Google Scholar
• Nandagopal R, Laverdière C, Mulrooney D, Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res. 2008;69:65–74.
   PubMedGoogle Scholar
• Wasilewski-Masker K, Kaste SC, Hudson MM, Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics. 2008;121:705–713.
   PubMed Web of Science ®Google Scholar
• Gunes AM, Can E, Saglam H, Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010;3:102–107.
   Google Scholar
• Kaste SC, Jones-Wallace D, Rose SR, Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15:728–734.
   PubMed Web of Science ®Google Scholar
• Muszynska-Roslan K, Konstantynowicz J, Panasiuk A, Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Pediatr Hematol Oncol. 2009;26:36–47.
   Web of Science ®Google Scholar
• Neyzi O, Ertugrul T. Büyüme gelişme bozuklukları: Pediatri. 2nd ed. İstanbul: Nobel Tıp Kitabevi; 1993:69–114.
   Google Scholar
• Goksen D, Darcan S, Coker M, Bone mineral density of healthy Turkish children and adolescents. J Clin Densitom. 2006;9:84–90.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Report of a WHO Study Group. Geneva: WHO; 1994. WHO Technical Report Series, No. 843.
   Google Scholar
• Kanis JA, Melton LJ 3rd, Christiansen C, The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–1141.
   PubMed Web of Science ®Google Scholar
• Holzer G, Krepler P, Koschat MA, Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br. 2003;85:231–237.
   Google Scholar
• Othman F, Guo CY, Webber C, Osteopenia in survivors of Wilms tumor. Int J Oncol. 2002;20:827–833.
   PubMedGoogle Scholar
• Sala A, Talsma D, Webber C, Bone mineral status after treatment of malignant lymphoma in childhood and adolescence. Eur J Cancer Care. 2007;16:373–379.
   Web of Science ®Google Scholar
• Kaste SC, Ahn H, Liu T, Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer. 2008;50:1032–1038.
   Google Scholar
• Odame I, Duckworth J, Talsma D, Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer. 2006;46:357–362.
   PubMed Web of Science ®Google Scholar
• Ruza E, Sierrasesúmaga L, Azcona C, Bone mineral density and bone metabolism in children treated for bone sarcomas. Pediatr Res. 2006;59:866–871.
   Google Scholar
• Maniadaki I, Stiakaki E, Germanics I, Evaluation of bone mineral density at different phases of therapy of childhood ALL. Pediatr Hematol Oncol. 2006;23:11–18.
   PubMed Web of Science ®Google Scholar
• Kaushik A, Bansal D, Khandelwal N, Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia. Indian Pediatr. 2009;46:245–248.
   Google Scholar
• Mandel K, Atkinson S, Barr RD, Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol. 2004;22:1215–1221.
   PubMed Web of Science ®Google Scholar
• Henderson RC, Madsen CD, Davis C, Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol. 1998;20:322–326.
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res. 1999;14:2002–2009.
   PubMed Web of Science ®Google Scholar
• de Schepper J, Hachimi-Idrissi S, Louis O, Bone metabolism and mineralization after cytotoxic chemotherapy including ifosfamide. Arch Dis Child. 1994;71:346–348.
   Google Scholar
• Alikaşifoğlu A, Yetgin S, Cetin M, Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Am J Hematol. 2005;80:113–118.
   Google Scholar
• van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006;46:88–93.
   Google Scholar
• Bath LF, Crofton PM, Evans AE, Bone turnover and growth during and after chemotherapy in children with solid tumors. Pediatr Res. 2004;55:224–230.
   Google Scholar
• Murphy AJ, Wells JC, Williams JE, Body composition in children in remission from acute lymphoblastic leukemia. Am J Clin Nutr. 2006;83:70–74.
   Google Scholar
• Papadakis V, Tan C, Heller G, Growth and final height after treatment for childhood Hodgkin disease. J Pediatr Hematol Oncol. 1996;18:272–276.
   Google Scholar
• Meacham LR, Gurney JG, Mertens AC, Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer. 2005;103:1730–1739.
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35:415–420.
   PubMedGoogle Scholar
• Oğuz A, Pinarli FG, Karadeniz C, Late effects of treatment on growth in childhood non-Hodgkin's lymphoma. Leuk Lymphoma. 2006;47:1283–1289.
   PubMed Web of Science ®Google Scholar
• Crofton PM, Ahmed SF, Wade JC, Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukemia. Eur J cancer. 1999;35:960–967.
   Google Scholar